LANCASTER, Calif.--(BUSINESS WIRE)--
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today announced that chairman and chief executive officer, Walt Woltosz, will present at the Needham Emerging Technology Conference on Wednesday, May 16, 2018, at 3:00 p.m. ET and will conduct one-on-one meetings throughout the day. The conference will be held at the Westin New York Grand Central Hotel in New York City.
For more information on Needham’s Emerging Technology Conference, please visit http://www.needhamco.com/.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at www.simulations-plus.com.
Follow us on Twitter | LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20180515005621/en/
